
NU and AstraZeneca Kazakhstan Signed Cooperation Agreement
More than 500 representatives from about 40 countries, including government and transnational companies’ leadership, world organizations, investors, businesses, and experts, gathered at the KGIR-2024 forum. The signed memorandum focuses on fostering educational, scientific, innovative, and research cooperation between a British-Swedish pharmaceutical company known for its strong commitment to medical and pharmacological research.








